BIOMAT Database Logo BIOMAT Database Logo

Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment. 1987

L Weinrauch, and M Katz, and J el-On

UI MeSH Term Description Entries
D007896 Leishmaniasis A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). Leishmania Infection,Infection, Leishmania,Infections, Leishmania,Leishmania Infections,Leishmaniases
D008297 Male Males
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000644 Quaternary Ammonium Compounds Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN Quaternary Ammonium Compound,Ammonium Compound, Quaternary,Ammonium Compounds, Quaternary,Compound, Quaternary Ammonium
D001558 Benzethonium Bactericidal cationic quaternary ammonium surfactant used as a topical anti-infective agent. It is an ingredient in medicaments, deodorants, mouthwashes, etc., and is used to disinfect apparatus, etc., in the food processing and pharmaceutical industries, in surgery, and also as a preservative. The compound is toxic orally as a result of neuromuscular blockade. Bencetonium Chloride,Benzethonium Chloride,Formula Magic,Hyamine 1622,Orchid Fresh II,Phemeride,Phemerol,Phemethryn,Puri-Clens,Quatrachlor,Solamin,Chloride, Bencetonium,Chloride, Benzethonium,Magic, Formula,Puri Clens,PuriClens

Related Publications

L Weinrauch, and M Katz, and J el-On
Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.
September 1985, British medical journal (Clinical research ed.),
L Weinrauch, and M Katz, and J el-On
Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment.
June 1991, Annals of tropical medicine and parasitology,
L Weinrauch, and M Katz, and J el-On
Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala.
November 2001, The American journal of tropical medicine and hygiene,
L Weinrauch, and M Katz, and J el-On
[Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
November 1994, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
L Weinrauch, and M Katz, and J el-On
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment of American cutaneous leishmaniasis: controlled study.
August 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L Weinrauch, and M Katz, and J el-On
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
January 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L Weinrauch, and M Katz, and J el-On
Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
January 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
L Weinrauch, and M Katz, and J el-On
Leishmania major: antileishmanial activity of methylbenzethonium chloride.
November 1986, The American journal of tropical medicine and hygiene,
L Weinrauch, and M Katz, and J el-On
Unsuccessful treatment of cutaneous leishmaniasis by Leishmania infantum with topical paromomycin.
July 2020, International journal of dermatology,
L Weinrauch, and M Katz, and J el-On
Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
November 1999, Journal of the European Academy of Dermatology and Venereology : JEADV,
Copied contents to your clipboard!